[CH3:1][O:2][C:3]([CH:5]1[CH2:14][C:13]2[N:12]=[C:11]([C:15]([F:18])([F:17])[F:16])[CH:10]=[CH:9][C:8]=2[C:7](=[O:19])[CH2:6]1)=[O:4].BrC(Cl)(Cl)Cl.N12CCCN=C1CCCCC2.CCCCCC>C(Cl)Cl.C(OCC)(=O)C>[CH3:1][O:2][C:3]([C:5]1[CH:14]=[C:13]2[C:8]([CH:9]=[CH:10][C:11]([C:15]([F:18])([F:16])[F:17])=[N:12]2)=[C:7]([OH:19])[CH:6]=1)=[O:4]A solution of 5-Oxo-2-trifluoromethyl-5,6,7,8-tetrahydro-quinoline-7-carboxylic acid methyl ester (50.0 g, 183.01 mmol) is dissolved in methylene chloride (500 ml) and treated drop wise with a solution of bromotrichloromethane (54.43 g, 274.51 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 55.72 g, 366.02 mmol) in methylene chloride (100 ml) at 0-5° C. After the addition is complete, the reaction mixture is allowed to warm to room temperature and stirred for 1 hr where TLC analysis (4:1 hexane:ethyl acetate) shows reaction completion. The reaction mixture is diluted with ethyl acetate and then washed successively with dilute aqueous hydrochloric acid and brine. The ethyl acetate phase is dried over anhydrous sodium sulphate, filtered, and concentrated in vacuo. The residue is purified by recrystallisation from hexane:ethyl acetate to give the title compound (47.13 g, 95%) as pale yellow crystals.
Loading…
